June 8, 2020 / 1:48 PM / a month ago

BRIEF-Avalon Globocare Announces Diagnostic Platform For Point-Of-Care Rapid Detection Of Covid-19 And Its Clinically Relevant Mutation Strains

June 8 (Reuters) - Avalon Globocare Corp:

* AVALON GLOBOCARE ANNOUNCES DIAGNOSTIC PLATFORM FOR POINT-OF-CARE RAPID DETECTION OF COVID-19 (SARS-COV-2) AND ITS CLINICALLY RELEVANT MUTATION STRAINS

* AVALON GLOBOCARE - ENTERED PARTNERSHIP WITH GENSKEY MEDICAL TECHNOLOGY CO. LTD. TO CO-DEVELOP & COMMERCIALIZE IGG/IGM, SARS-COV-2 DETECTION SYSTEMS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below